Peter Lu, Partner and Global Head of the China Practice at McDermott Will & Emery, discusses China’s opening of its health industry to international investors.
Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.
Jeremy MacMahon, Yi-Hua Tsai, and Pamela Lein from the Department of Molecular Biosciences, UC Davis School of Veterinary Medicine, explore how shellfish poisoning is affecting human and animal health.
Affecting 10 million pregnancies worldwide, this piece explores the ways preeclampsia testing is utilised to save lives, the hidden dangers of the condition and the demographics that are at most risk.
Mary Hardcastle at RapidAI looks at the advancements in health tech, explaining what hospitals need to do to implement Artificial Intelligence in the ER.
